concept

T CELL

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about T CELL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2399Connections
5Hypotheses
0Analyses
50Outgoing
50Incoming
11Experiments
0Debates

Summary

T CELL is a concept in neurodegeneration research. Key relationships include: co discussed, activates, associated with. Associated with ALZHEIMER'S DISEASE, CANCER, ENCEPHALITIS. Connected to 200 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameT CELL
Key Genes/ProteinsACHE, AKT, AMPK, AMYLOID
Related DiseasesALS, ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS

Pathway Diagram

graph TD
    T_CELL["T CELL"]
    COMPLEMENT["COMPLEMENT"] -->|"expressed in"| T_CELL
    HSPG2["HSPG2"] -->|"expressed in"| T_CELL
    CANCER["CANCER"] -->|"expressed in"| T_CELL
    TCR["TCR"] -->|"expressed in"| T_CELL
    CD40["CD40"] -->|"expressed in"| T_CELL
    AQP4["AQP4"] -->|"expressed in"| T_CELL
    HSPA1A["HSPA1A"] -->|"expressed in"| T_CELL
    APOPTOSIS["APOPTOSIS"] -->|"expressed in"| T_CELL
    NEURODEGENERATION["NEURODEGENERATION"] -->|"expressed in"| T_CELL
    HSP70["HSP70"] -->|"expressed in"| T_CELL

Outgoing (134)

TargetRelationTypeStr
Lewy Body Dementiainvolved_indisease0.90
Brain Hominginvolved_inprocess0.85
Dopaminergic Neuroninteracts_withcell_type0.85
tumor immune microenvironmentexpressed_inpathway0.85
Amyotrophic Lateral Sclerosisinvolved_indisease0.80

Incoming (2265)

SourceRelationTypeStr
TET2regulatesentity0.90
anti-PD-1 therapytargetsdrug0.90
PARKINSON'S DISEASEassociated_withdisease0.90
NEURODEGENERATIONassociated_withdisease0.82
Senescence-Associated Secretory Phenotypeexpressed_inphenotype0.80

Targeting Hypotheses (5)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Senescent Cell ASM-Complement Cascade Intervention 0.852 neurodegeneration Lipid raft composition changes in synapt
Senescent Cell Mitochondrial DNA Release 0.742 neurodegeneration Senolytic therapy for age-related neurod
Soluble GAG-Mimetic Peptides Compete with HSPG for Tau Seed 0.510 neurodegeneration Investigate prion-like spreading of tau
TH-neuron-restricted RGS6 rescue to test cell-autonomous the 0.460 neurodegeneration Does RGS6 upregulation or D2 autorecepto
Paraneoplastic myelopathies involve CD8+ T cell recognition 0.450 neuroinflammation What are the specific pathophysiological

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (11)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Mobile App-Based Intervention for BPSD in Community-Dwelling Dementia clinical dementia with behavioral and p 0.950 0.00 human patients proposed N/A
iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD exploratory Parkinson's disease 0.900 0.00 iPSC-derived dopaminergic neur proposed N/A
Proposed experiment from debate on Senolytics targeting p16/p21+ senes falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe clinical Neurodegeneration 0.400 0.50 in_silico proposed $180,000
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts clinical ALS 0.400 0.50 human proposed $6,550,000
cGAS-STING Pathway Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $7,100,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Regulated Necrosis Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Traumatic Brain Injury and Alzheimer's Disease Relationship validation Alzheimer's Disease 0.400 0.50 human proposed $3,000,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] Yu CH, Davidson S, Harapas CR, Hilton JB Cell 2020 2
Past, present and future perspectives on the science of aging. [PMID:41566049] Fabrisia Ambrosio; Maxim N Artyomov; Ste Nature aging 2026 0
Stimuli-responsive nanoplatforms for precision activation of the STING pathway i [PMID:41668757] ["Bi D", "Yang X", "Wang Y", "Yong J", " Frontiers in immunology 2026 0
Decoding senescent drivers in Alzheimer's disease: From bench to bedside. [PMID:41344577] ["Zhou R", "Lin X", "Liao Z", "Lin J", " Ageing research reviews 2026 0
Role of NEIL1 in genome maintenance. [PMID:40010204] ["McCullough A", "Minko I", "Luzadder M" DNA repair 2025 0
Bionanoconjugates in Neurodegeneration: Peptide-Nanoparticle Alliances for Next- [PMID:41199078] ["Ranjitha V", "Kumar A", "Kaalappa P"] Pharmaceutical research 2025 0
Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven imm [PMID:40203808] ["Lai P", "Liu L", "Bancaro N", "Troiani Immunity 2025 0
Apheresis for senescence: Targeting the senescence-associated secretory phenotyp [PMID:40651559] ["Akgun Y"] Ageing research reviews 2025 0
Methodological influences on circulating cell-free-mitochondrial and nuclear DNA [PMID:40080226] ["Daubermann C", "Herhaus B", "Neuberger Molecular biology reports 2025 0
Innate immune sensing of Z-nucleic acids by ZBP1-RIPK1 axis drives neuroinflamma [PMID:40902587] ["Song Z", "Xie X", "Chen Y", "Zhang B", Immunity 2025 0
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746] ["Sanadgol N", "Abedi M", "Hashemzaei M" Journal of nanobiotechnology 2025 0
Antileukemic potential of methylated indolequinone MAC681 through immunogenic ne [PMID:38704604] ["Orlikova-Boyer B", "Lorant A", "Gajula Biomarker research 2024 0
Enhancing Radiofrequency Ablation for Hepatocellular Carcinoma: Nano-Epidrug Eff [PMID:39548919] ["Li X", "Liu Y", "Ke J", "Wang Z", "Han Advanced materials (Deerfield 2024 0
The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellul [PMID:39490400] Zhang Y, Zou M, Wu H, Zhu J, Jin T Neurobiology of disease 2024 0
mtDNA release promotes cGAS-STING activation and accelerated aging of postmitoti [PMID:39039044] ["Li Y", "Cui J", "Liu L", "Hambright W" Cell death & disease 2024 0
Senescent glia link mitochondrial dysfunction and lipid accumulation. [PMID:38839958] ["Byrns C", "Perlegos A", "Miller K", "J Nature 2024 0
Apoptotic stress causes mtDNA release during senescence and drives the SASP. [PMID:37821702] ["Victorelli S", "Salmonowicz H", "Chapm Nature 2023 0
Exposome and unhealthy aging: environmental drivers from air pollution to occupa [PMID:37688657] Pandics T, Major D, Fazekas-Pongor V, Sz GeroScience 2023 0
cGAS-STING drives ageing-related inflammation and neurodegeneration. [PMID:37532932] Gulen MF, Samson N, Keller A, Schwabenla Nature 2023 0
Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STI [PMID:36964253] ["Kim J", "Kim H", "Chung J"] Experimental & molecular medic 2023 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning T CELL in their description or question text

No additional research found